Skip to main content
David Lally, MD, Ophthalmology, Springfield, MA

DavidRyanLallyMD

Ophthalmology Springfield, MA

Retinal Disease

Physician

Dr. Lally is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lally's full profile

Already have an account?

  • Office

    3640 Main St
    Ste 201
    Springfield, MA 01107
    Phone+1 413-732-2333
    Fax+1 413-732-8065

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Surgical Retina and Vitreous, 2013 - 2015
  • Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye Hospital
    Sidney Kimmel Medical College at Thomas Jefferson University/Wills Eye HospitalResidency, Ophthalmology, 2010 - 2013
  • Christ Hospital
    Christ HospitalInternship, Internal Medicine, 2009 - 2010
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2009

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2013 - 2026
  • CT State Medical License
    CT State Medical License 2018 - 2020
  • DE State Medical License
    DE State Medical License 2012 - 2015
  • PA State Medical License
    PA State Medical License 2010 - 2013
  • OH State Medical License
    OH State Medical License 2009 - 2010
  • American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Press Mentions

  • Geographic Atrophy Drug Development Meets Its Future
    Geographic Atrophy Drug Development Meets Its FutureDecember 8th, 2022
  • Ocuphire Pharma Announces Financial Results for Third Quarter 2022 and Provides Corporate Update
    Ocuphire Pharma Announces Financial Results for Third Quarter 2022 and Provides Corporate UpdateNovember 4th, 2022
  • Ocuphire Pharma : Announces Financial Results for the Second Quarter 2022 and Provides Corporate Update - Form 8-K
    Ocuphire Pharma : Announces Financial Results for the Second Quarter 2022 and Provides Corporate Update - Form 8-KAugust 15th, 2022
  • Join now to see all

Professional Memberships